An Evaluation of the Effects of Thimerosal on Neurodevelopmental Disorders Reported Following DTP and Hib Vaccines in Comparison to DTPH Vaccine in the United States

By Geier David   Geier Mark  

Journal of Toxicology and Environmental Health, Vol. 69, Iss. 15, 2006-09 ,pp. : 1481-1495

Taylor & Francis Ltd

Access to resources Recommend Favorite

EMEA supports safety of thiomersal-containing vaccines

By  

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines

By Tegenge Million   Mitkus Robert  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 40, Iss. 5, 2013-10 ,pp. : 545-556

Springer Publishing Company

Access to resources Recommend Favorite

When science is not enough – a risk/benefit profile of thiomersal-containing vaccines

By Clements C John   McIntyre Peter B  

Expert Opinion on Drug Safety, Vol. 5, Iss. 1, 2006-01 ,pp. : 17-29

Informa Healthcare

Access to resources Recommend Favorite

The benefit-risk balance of thiomersal-containing vaccines remains overwhelmingly positive

By  

Inpharma, Vol. 1, Iss. 1376, 2003-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite